Clinical Trials Browser

Phase 3 × Leukemia × Alemtuzumab × Clear all

NCT00564512 2013-07-25

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell